NeoGenomics Inc (NEO)
NASDAQ HEALTHCAREMoving Averages
SMA 200
$10.40
Price above
Company Profile
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
Sector
HEALTHCARE
Industry
DIAGNOSTICS & RESEARCH
Market Cap
$1.84B
P/E Ratio
None
EPS
$-0.77
Beta
1.738
Dividend Yield
0.00%
52-Week High
$15.57
52-Week Low
$4.72
Similar stocks in DIAGNOSTICS & RESEARCH
TMO
Thermo Fisher Scientific Inc
RSI 69.0
ILMN
Illumina Inc
RSI 67.0
MTD
Mettler-Toledo International Inc
RSI 71.0
CSTL
Castle Biosciences Inc
RSI 71.0
FONR
Fonar Corp
RSI 75.0
CRL
Charles River Laboratories International Inc
RSI 60.0
BDSX
Biodesix Inc
RSI 54.0
NTRA
Natera Inc
RSI 56.0
WGS
GeneDx Holdings Corp - Class A
RSI 53.0
DGX
Quest Diagnostics Inc
RSI 36.0
Data last updated: July 14, 2026 at 4:52 AM EDT
Track NEO for free
Get e-mail RSI alerts when NeoGenomics Inc enters oversold or overbought territory. Free forever.
Add Alert